Your browser doesn't support javascript.
loading
Next-generation antibody-drug conjugates revolutionize the precise classification and treatment of HER2-expressing breast cancer.
Dai, Lei-Jie; Li, Yu-Wei; Ma, Ding; Shao, Zhi-Ming; Jiang, Yi-Zhou.
Affiliation
  • Dai LJ; Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
  • Li YW; Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
  • Ma D; Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
  • Shao ZM; Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
  • Jiang YZ; Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Cancer Biol Med ; 20(10)2023 10 12.
Article in En | MEDLINE | ID: mdl-37823691
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Immunoconjugates Limits: Female / Humans Language: En Journal: Cancer Biol Med Year: 2023 Document type: Article Affiliation country: China Country of publication: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Immunoconjugates Limits: Female / Humans Language: En Journal: Cancer Biol Med Year: 2023 Document type: Article Affiliation country: China Country of publication: China